Trends in COVID-19 Treatment and Long COVID Symptoms
Author Information
Author(s): Baalbaki Nadia, Verbeek Sien T., Bogaard Harm Jan, Blankestijn Jelle M., van den Brink Vera C., Cornelissen Merel E. B., Twisk Jos W. R., Golebski Korneliusz, Maitland-van der Zee Anke H.
Primary Institution: Amsterdam UMC
Hypothesis
Can pre-COVID pharmacotherapy predict long COVID symptoms?
Conclusion
Medication history can be a valuable health status indicator for personalized management of long COVID.
Supporting Evidence
- 10-30% of COVID-19 cases experience long COVID.
- Pre-existing medication history may indicate susceptibility to long COVID.
- Medication usage peaked during acute COVID-19, particularly corticosteroids and anticoagulants.
- Longitudinal data showed stable use of alimentary tract medications across all phases.
- Regression analyses indicated associations between pre-COVID medications and long COVID symptoms.
Takeaway
This study looked at how medications used before and during COVID-19 can help understand long-lasting symptoms after the infection.
Methodology
Descriptive analysis of pharmacotherapy patterns and regression analyses to assess associations with long COVID outcomes.
Potential Biases
Self-reported medication usage may introduce recall bias.
Limitations
The study's observational design limits causal inference, and the sample size may restrict generalizability.
Participant Demographics
Mean age of 54.2 years, 49.5% female, with a history of moderate COVID-19 and high hospitalization rates.
Statistical Information
P-Value
0.03
Confidence Interval
95% CI: 1.16–28.54
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website